微电生理股价涨5.22%,华宝基金旗下1只基金位居十大流通股东,持有461.24万股浮盈赚取511.97万元

Core Insights - Microelectrophysiology shares rose by 5.22% on October 22, reaching a price of 22.36 CNY per share, with a trading volume of 89.29 million CNY and a turnover rate of 3.25%, resulting in a total market capitalization of 10.52 billion CNY [1] Company Overview - Shanghai Microelectrophysiology Medical Technology Co., Ltd. was established on August 31, 2010, and went public on August 31, 2022. The company specializes in the research, development, production, and sales of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation treatment [1] - The revenue composition of the company includes catheter products at 71.77%, other products at 20.22%, equipment products at 7.24%, and leasing services at 0.77% [1] Shareholder Information - Huabao Fund's Huabao CSI Medical ETF (512170) is among the top ten circulating shareholders of Microelectrophysiology, having increased its holdings by 159,200 shares in the second quarter, totaling 4.61 million shares, which represents 3.69% of the circulating shares. The estimated floating profit today is approximately 5.12 million CNY [2] - The Huabao CSI Medical ETF (512170) was established on May 20, 2019, with a current scale of 26.15 billion CNY. Year-to-date returns are 14.17%, ranking 3282 out of 4218 in its category; one-year returns are 9.8%, ranking 3287 out of 3869; and since inception, returns are 11.88% [2]